# Immuneering (stock symbol: IMRX) Logo in transparent PNG and SVG formats

## Immuneering Logo large

### Immuneering Logo large Download PNG (43.2 KB)

![Immuneering Logo large Download PNG (43.2 KB)](/img/orig/IMRX_BIG-5caf67c6.png)

### Immuneering Logo large Download SVG (11.68 KB)

![Immuneering Logo large Download SVG (11.68 KB)](/img/orig/IMRX_BIG-7255352e.svg)

## Immuneering Logo icon format

### Immuneering Logo icon format Download PNG (51.42 KB)

![Immuneering Logo icon format Download PNG (51.42 KB)](/img/orig/IMRX-3603170b.png)

### Immuneering Logo icon format Download SVG (2.58 KB)

![Immuneering Logo icon format Download SVG (2.58 KB)](/img/orig/IMRX-364960d9.svg)

## Immuneering Logo large for dark backgrounds

### Immuneering Logo large for dark backgrounds Download PNG (42.98 KB)

![Immuneering Logo large for dark backgrounds Download PNG (42.98 KB)](/img/orig/IMRX_BIG.D-a0ee118d.png)

### Immuneering Logo large for dark backgrounds Download SVG (11.66 KB)

![Immuneering Logo large for dark backgrounds Download SVG (11.66 KB)](/img/orig/IMRX_BIG.D-f8c5b80c.svg)

## About Immuneering

Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed to target components of the MAPK or mTOR pathway; and two discovery stage neuroscience programs. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts. Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited.

1. Website domain: immuneering.com
2. Employees: 74
3. Marketcap: $0.29 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
